Gunnar Kvalheim

High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial

Harry C. Schouten, Wendi Qian, Stein Kvaløy et al. · Journal of Clinical Oncology · 2003 · 479 citations

Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

Petter Woll, Una Kjällquist, Onima Chowdhury et al. · Cancer Cell · 2014 · 318 citations · Full text

Hematological Malignancy, Bone Marrow Failure, Myelodysplastic Syndromes +9

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma

Einar Osland Vik-Mo, Marta Nyakas, Birthe Mikkelsen et al. · Cancer Immunology Immunotherapy · 2013 · 302 citations · Full text

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

Elin Borgen, Bjørn Naume, Jahn M. Nesland et al. · Cytotherapy · 1999 · 265 citations

Immunostained Cells, Immunocytochemical Technique, Oncology +13

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

Paal Brunsvig, Steinar Aamdal, Gunnar Kvalheim et al. · Cancer Immunology Immunotherapy · 2006 · 243 citations · Full text

Telomerase Peptide Vaccination, Cancer Immunosurveillance, Phase I/ii Study +11